{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:52:36Z","timestamp":1781581956184,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The potential role of CISD2 as a predictive marker in DLBCL patients treated with the R-CHOP regimen was investigated through bioinformatics analysis and clinical cohort studies. DLBCL cell lines (SUDHL-4 and HBL-1) were employed in this research. Adenoviral (AV) plasmids were used to either silence or overexpress CISD2 in these DLBCL cell lines. Additionally, the induction of ferroptosis in DLBCL cell lines was assessed. Various parameters, including cell proliferation, intracellular free iron levels, lipid peroxides, reactive oxygen species (ROS), and mitochondrial membrane potential (MMP), were measured. Furthermore, the expression of proteins associated with ferroptosis and ferritinophagy was analyzed. Drug-resistant DLBCL cell lines were developed by gradually increasing doxorubicin (DOX) concentration over 6\u00a0months. The biological role of CISD2 in these drug-resistant DLBCL cell lines was subsequently assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Elevated CISD2 levels were found to be associated with decreased sensitivity of DLBCL patients to the R-CHOP regimen, as indicated by bioinformatics and clinical cohort analysis. Silencing CISD2 significantly reduced cell proliferation, increased iron accumulation, depleted glutathione (GSH), and elevated malondialdehyde (MDA) levels, alongside the accumulation of ROS and increased MMP. Additionally, BECN1 and NCOA4 expressions were upregulated, while p62, FTH1, and GPX4 expressions were downregulated. Conversely, overexpression of CISD2 reversed these effects. Treatment of DLBCL cell lines with Erastin led to decreased CISD2 levels. Notably, in drug-resistant DLBCL cell lines, CISD2 knockdown promoted ferroptosis and ferritinophagy, restoring sensitivity to DOX and enhancing the efficacy of Erastin treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings suggest that CISD2 may play a role in the drug resistance observed in DLBCL patients. Inhibition of CISD2 could enhance ferroptosis and ferritinophagy, potentially improving the sensitivity of DLBCL cells to DOX treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1482354","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:10:10Z","timestamp":1731474610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy"],"prefix":"10.3389","volume":"15","author":[{"given":"Chaofeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/hmg\/dds048","article-title":"Bcl-2-associated autophagy regulator naf-1 required for maintenance of skeletal muscle","volume":"21","author":"Chang","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4161\/auto.20054","article-title":"BCL2-CISD2: an ER complex at the nexus of autophagy and calcium homeostasis?","volume":"8","author":"Chang","year":"","journal-title":"Autophagy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4161\/auto.5.7.9351","article-title":"Cisd2 mediates mitochondrial integrity and life span in mammals","volume":"5","author":"Chen","year":"2009","journal-title":"Autophagy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1080\/10428194.2020.1869228","article-title":"Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma","volume":"62","author":"Cherng","year":"2021","journal-title":"Leukemia and Lymphoma"},{"key":"B5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for P53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10890","DOI":"10.1073\/pnas.1612736113","article-title":"Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its fe-S clusters","volume":"113","author":"Darash-Yahana","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/jcs.178293","article-title":"Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells","volume":"129","author":"Holt","year":"2016","journal-title":"J. Cell Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1515\/oncologie-2023-0074","article-title":"CISD2 protects against Erastin induced hepatocellular carcinoma ferroptosis by upregulating FSP1","volume":"25","author":"Hou","year":"2023","journal-title":"Oncologie"},{"key":"B10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2021.09.013","article-title":"Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression","volume":"176","author":"Karmi","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","article-title":"CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death and Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"693959","DOI":"10.3389\/fmed.2021.693959","article-title":"Ferroptosis-related genes in bronchoalveolar lavage fluid serves as prognostic biomarkers for idiopathic pulmonary fibrosis","volume":"8","author":"Li","year":"2021","journal-title":"Front. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-022-00383-z","article-title":"Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of P62\u2013Keap1\u2013NRF2 pathway","volume":"27","author":"Li","year":"2022","journal-title":"Cell. and Mol. Biol. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111472","DOI":"10.1016\/j.biopha.2021.111472","article-title":"CISD2 plays a role in age-related diseases and cancer","volume":"138","author":"Liao","year":"2021","journal-title":"Biomed. and Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e10308","DOI":"10.7554\/eLife.10308","article-title":"Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis","volume":"4","author":"Mancias","year":"2015","journal-title":"eLife"},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fonc.2019.00107","article-title":"Dysregulation of cell survival in diffuse large B cell lymphoma: mechanisms and therapeutic targets","volume":"9","author":"Miao","year":"2019","journal-title":"Front. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/ars.2018.7502","article-title":"NEET proteins: a new link between iron metabolism, reactive oxygen species, and cancer","volume":"30","author":"Mittler","year":"2019","journal-title":"Antioxidants and Redox Signal."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1182\/blood-2019-123083","article-title":"Potential factors that impact lenalidomide\/R-CHOP efficacy in previously untreated diffuse large B-cell lymphoma in the ROBUST and ECOG-ACRIN 1412 studies","volume":"134","author":"Nowakowski","year":"2019","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beha.2018.07.014","article-title":"Management of relapsed\/refractory DLBCL","volume":"31","author":"Sarkozy","year":"2018","journal-title":"Best Pract. and Res. Clin. Haematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"104249","DOI":"10.1016\/j.jri.2024.104249","article-title":"A preliminary study unveils CISD2 as a ferroptosis-related therapeutic target for recurrent spontaneous abortion through immunological analysis and two-sample mendelian randomization","volume":"163","author":"Shangguan","year":"2024","journal-title":"J. Reproductive Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"118954","DOI":"10.1016\/j.bbamcr.2021.118954","article-title":"CISD2 maintains cellular homeostasis","volume":"1868","author":"Shen","year":"2021","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Cell Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"14676","DOI":"10.1073\/pnas.1313198110","article-title":"NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth","volume":"110","author":"Sohn","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/cancers15030835","article-title":"The immunology of DLBCL","volume":"15","author":"Takahara","year":"2023","journal-title":"Cancers"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1093\/hmg\/ddu193","article-title":"Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+ homeostasis","volume":"23","author":"Wang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1015042","DOI":"10.3389\/fonc.2022.1015042","article-title":"A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma","volume":"12","author":"Wang","year":"","journal-title":"Front. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10528-022-10267-8","article-title":"CISD2 promotes proliferation of colorectal cancer cells by inhibiting autophagy in a wnt\/\u03b2-catenin-signaling-dependent pathway","volume":"61","author":"Wang","year":"2022","journal-title":"Biochem. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41420-023-01753-y","article-title":"Ferritinophagy: research advance and clinical significance in cancers","volume":"9","author":"Wang","year":"","journal-title":"Cell Death Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.seminhematol.2023.11.004","article-title":"Epidemiology and etiology of diffuse large B-cell lymphoma","author":"Wang","year":"2023","journal-title":"Seminars Hematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12672-023-00725-z","article-title":"RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis","volume":"14","author":"Wu","year":"2023","journal-title":"Discov. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1073\/pnas.1819728116","article-title":"Chaperone-mediated autophagy is involved in the execution of ferroptosis","volume":"116","author":"Wu","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e19799","DOI":"10.1016\/j.heliyon.2023.e19799","article-title":"Ferroptosis, autophagy, tumor and immunity","volume":"9","author":"Xie","year":"2023","journal-title":"Heliyon"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e15476","DOI":"10.7717\/peerj.15476","article-title":"Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment","volume":"11","author":"Xu","year":"2023","journal-title":"PeerJ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"14014","DOI":"10.3390\/ijms232214014","article-title":"Rejuvenation: turning back time by enhancing CISD2","volume":"23","author":"Yeh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1038\/s41598-023-38568-x","article-title":"Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma","volume":"13","author":"Zhang","year":"","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1277695","DOI":"10.3389\/fimmu.2023.1277695","article-title":"Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma","volume":"14","author":"Zhang","year":"","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1039951","DOI":"10.3389\/fgene.2022.1039951","article-title":"Ferroptosis in lymphoma: emerging mechanisms and a novel therapeutic approach","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1002\/cam4.2977","article-title":"Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein","volume":"9","author":"Zhu","year":"2020","journal-title":"Cancer Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1482354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:10:14Z","timestamp":1731474614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1482354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":43,"alternative-id":["10.3389\/fphar.2024.1482354"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1482354","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"article-number":"1482354"}}